ES2195335T3 - Nuevos productos intermedios y procedimiento para la preparacion de los mismos. - Google Patents

Nuevos productos intermedios y procedimiento para la preparacion de los mismos.

Info

Publication number
ES2195335T3
ES2195335T3 ES98921669T ES98921669T ES2195335T3 ES 2195335 T3 ES2195335 T3 ES 2195335T3 ES 98921669 T ES98921669 T ES 98921669T ES 98921669 T ES98921669 T ES 98921669T ES 2195335 T3 ES2195335 T3 ES 2195335T3
Authority
ES
Spain
Prior art keywords
preparation
intermediate products
procedure
same
new intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98921669T
Other languages
English (en)
Inventor
Maria Bakonyi
Nagy Marianna Csatarine
Leventene Molnar
Zoltan Makovi
Piroska Jobb
Tiborne Bai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of ES2195335T3 publication Critical patent/ES2195335T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Press Drives And Press Lines (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se presenta un proceso par la preparación de 2-[(2-tienil)-etilamino]-2(2-halogenofenil)-acetamidas de la fórmula general (VII) comenzando a partir de nitrilos de la fórmula general (I). Los compuestos de la fórmula general (VII) son productos intermedios de gran valor.
ES98921669T 1997-05-13 1998-05-11 Nuevos productos intermedios y procedimiento para la preparacion de los mismos. Expired - Lifetime ES2195335T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700884A HU225503B1 (en) 1997-05-13 1997-05-13 Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them

Publications (1)

Publication Number Publication Date
ES2195335T3 true ES2195335T3 (es) 2003-12-01

Family

ID=89995117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98921669T Expired - Lifetime ES2195335T3 (es) 1997-05-13 1998-05-11 Nuevos productos intermedios y procedimiento para la preparacion de los mismos.

Country Status (13)

Country Link
US (1) US6258961B1 (es)
EP (1) EP0981524B1 (es)
JP (1) JP4282770B2 (es)
AT (1) ATE238294T1 (es)
AU (1) AU7444798A (es)
BR (1) BR9809111B1 (es)
CA (1) CA2289545C (es)
DE (1) DE69813792T2 (es)
ES (1) ES2195335T3 (es)
HU (1) HU225503B1 (es)
NO (1) NO324039B1 (es)
PT (1) PT981524E (es)
WO (1) WO1998051681A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) * 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
US6858734B2 (en) * 2003-04-23 2005-02-22 Rhodia Pharma Solutions Inc. Preparation of (S)-Clopidogrel and related compounds
WO2004108665A2 (en) * 2003-04-24 2004-12-16 Sun Pharmaceutical Industries Limited A process for preparation of clopidogrel
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
CA2676121A1 (en) 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
PL1589019T3 (pl) * 2004-04-20 2008-12-31 Ratiopharm Gmbh Stereoselektywny sposób wytwarzania klopidogrelu
WO2006034451A2 (en) * 2004-09-21 2006-03-30 Teva Pharmaceutical Industries Ltd. Crystalline clopidogrel hydrobromide and processes for preparation thereof
MX2007010267A (es) * 2005-02-24 2007-09-11 Teva Pharma Base de clopidogrel adecuada para formulacion farmaceutica y preparacion de ella.
CA2650471A1 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN103483356B (zh) * 2013-09-30 2016-01-13 浙江美诺华药物化学有限公司 一种（s）-氯吡格雷的硫酸盐或盐酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
BR9809111B1 (pt) 2009-05-05
WO1998051681A1 (en) 1998-11-19
JP2001525818A (ja) 2001-12-11
HUP9700884A3 (en) 2000-06-28
BR9809111A (pt) 2000-08-01
NO324039B1 (no) 2007-07-30
AU7444798A (en) 1998-12-08
NO995532L (no) 1999-12-13
HU225503B1 (en) 2007-01-29
DE69813792T2 (de) 2004-01-29
NO995532D0 (no) 1999-11-12
EP0981524B1 (en) 2003-04-23
CA2289545C (en) 2006-12-12
US6258961B1 (en) 2001-07-10
HU9700884D0 (en) 1997-07-28
EP0981524A1 (en) 2000-03-01
JP4282770B2 (ja) 2009-06-24
PT981524E (pt) 2003-08-29
DE69813792D1 (de) 2003-05-28
ATE238294T1 (de) 2003-05-15
CA2289545A1 (en) 1998-11-19
HUP9700884A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
ES2195335T3 (es) Nuevos productos intermedios y procedimiento para la preparacion de los mismos.
ES2172141T3 (es) Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa.
EE9900259A (et) Ühendi uus vorm
EE200100246A (et) Asendatud fenüültsükloheksüülühendite uued esterderivaadid
NO990756L (no) FremgangsmÕte for fremstilling av mellomprodukter for florfenikol
FI915573A (fi) Foerfarande foer framstaellning av cellulosaformkroppar.
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
ATE214698T1 (de) Neue carbamazepin hapten analoge
CA2288637A1 (en) Process for the preparation of 2-[(2-thienyl)-ethylamino-(2-halogenophe nyl)-acetonitriles
PL310486A1 (en) Novel compounds, derivatives of genistein
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
TR199900321T2 (xx) N-(1-nbutil - 4 - piperidil)metil) -3,4-dihidro -2H- (1,3) oksazino (3.2A) indol-10- Karboksamit haz�rlama prosesi ve prosesteki tuzlar ve ara �r�nler.
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
ID24327A (id) Produksi senyawa-senyawa avermektin
NO20001896D0 (no) Fremgangsmõte for syntese av klorpurinmellomprodukter
NO974635D0 (no) Fremgangsmåte for fremstilling av i det vesentlige rene somere av <alfa>-bis-oksimer
BR9306924A (pt) Derivados de 1,3-oxazolidina pirdil-substituídos oidetos de 1,2,4-ditioz lio de novos compostos de partida
ES2178080T3 (es) Procedimiento para la preparacion de derivados de alcoxi-o ariloxi-pirazina.
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
FR2770214B1 (fr) Procede de preparation d'un benzamide halogene
LV12147A (lv) 2-Okso-4-fenilbutanskabes etilestera sinteze no 2,2-dietoksi-4-fenilbutenskabes etilestera
CO4700374A1 (es) Intermediarios herbicidas de quinolina
TH42384A (th) อนุพันธ์ d-โปรไลน์